Brief: Monopar Therapeutics Announces Pricing Of $19.2 Million Public Offering Of Common Stock
29/10/2024 01:16
Oct 28 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR THERAPEUTICS INC. ANNOUNCES PRICING OF $19.2
MILLION
PUBLIC OFFERING OF COMMON STOCK
* MONOPAR THERAPEUTICS INC - PRICES PUBLIC OFFERING AT
$16.25 PER
SHARE
Source text: ID:nGNX34vfdV
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla